| Cancer Mechanisms and Therapy | Lifetime | 8 | TW 1 | 99.73 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 20 | TW 1 | 99.88 |
| Colorectal Cancer Treatments and Studies | Lifetime | 114 | TW 1 | 99.57 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 256 | TW 1 | 99.37 |
| Liver physiology and pathology | Lifetime | 72 | TW 1 | 99.16 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 300 | TW 1 | 99.13 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 186 | TW 1 | 99.04 |
| Hepatitis B Virus Studies | Lifetime | 288 | TW 9 | 99.15 |
| Ferroptosis and cancer prognosis | Lifetime | 158 | TW 1 | 97.83 |
| Lymphoma Diagnosis and Treatment | Lifetime | 413 | TW 1 | 98.90 |
| Liver Disease Diagnosis and Treatment | Lifetime | 977 | TW 17 | 98.81 |
| Lung Cancer Treatments and Mutations | Lifetime | 638 | TW 7 | 98.64 |
| Cancer, Lipids, and Metabolism | Lifetime | 585 | TW 2 | 97.86 |
| Renal cell carcinoma treatment | Lifetime | 518 | TW 2 | 97.84 |
| Viral-associated cancers and disorders | Lifetime | 513 | TW 2 | 97.35 |
| Retinoids in leukemia and cellular processes | Lifetime | 423 | TW 2 | 96.54 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 484 | TW 2 | 96.41 |
| Fibroblast Growth Factor Research | Lifetime | 321 | TW 1 | 95.52 |
| Cell death mechanisms and regulation | Lifetime | 813 | TW 13 | 94.93 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 423 | TW 1 | 95.20 |
| Multiple and Secondary Primary Cancers | Lifetime | 831 | TW 2 | 92.57 |
| Curcumin's Biomedical Applications | Lifetime | 520 | TW 9 | 89.16 |
| Kruppel-like factors research | Lifetime | 879 | TW 6 | 87.53 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 12 | TW 1 | 99.81 |
| Cancer Mechanisms and Therapy | 2021-2025 | 5 | TW 1 | 99.46 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 63 | TW 1 | 98.99 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 259 | TW 1 | 98.99 |
| Liver physiology and pathology | 2021-2025 | 32 | TW 1 | 95.22 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 163 | TW 2 | 96.59 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 402 | TW 3 | 96.95 |
| Hepatitis B Virus Studies | 2021-2025 | 382 | TW 31 | 93.63 |
| Ferroptosis and cancer prognosis | 2021-2025 | 891 | TW 8 | 90.24 |
| Advanced Breast Cancer Therapies | 2021-2025 | 991 | TW 12 | 82.94 |
| Kruppel-like factors research | 2021-2025 | 399 | TW 1 | 66.39 |
| Fibroblast Growth Factor Research | 2021-2025 | 744 | TW 5 | 61.52 |
